| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 160,127 | 158,272 | 154,738 | 196,011 | | Cost of Revenue | 34,368 | 14,410 | 57,422 | 11,161 | | | Gross Profit | 125,759 | 143,862 | 97,316 | 184,850 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 57,037 | 82,673 | 37,269 | 102,228 | | Non Recurring | 2,759 | (1,280) | 128,862 | 461,237 | | Others | 33,246 | 36,645 | 37,892 | 36,776 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 35,733 | 25,824 | (106,707) | (415,391) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,464 | 412 | 19,687 | 3,837 | | Earnings Before Interest And Taxes | 36,634 | 26,699 | (87,465) | (411,554) | | Interest Expense | 17,466 | 17,646 | 18,374 | 18,959 | | Income Before Tax | 19,168 | 9,053 | (105,839) | (430,513) | | Income Tax Expense | 3,313 | 6,358 | (18,800) | (147,826) | | Minority Interest | 527 |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 15,855 | 2,695 | (87,039) | (282,687) | | | Non-recurring Events | | Discontinued Operations | 245 | (109) | (108) | (150) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 16,627 | 2,586 | (87,147) | (282,837) | | Preferred Stock And Other Adjustments | (1,689) | 197 | 1,492 |
-
| | | Net Income Applicable To Common Shares | $14,938 | $2,783 | ($85,655) | ($282,837) |
|
0.51% Nasdaq 
Income Statement
